According to an internal paper published on Sunday, Dutch health insurance companies no longer want to pay for expensive medication for rare and incurable diseases, on the grounds that they prolong the lives of patients only for a short time. A cynical calculation, cautions the liberal daily NRC Handelsblad: "These are cold numbers, and this is a harsh conclusion. But they point to a difficult emotional debate, which is unavoidable. Essentially it revolves around the question of how much we value human life and its quality. How much is society prepared to pay out in premiums and taxes for expensive treatments of rare diseases? The same goes for treatment of incurable diseases which only prolongs or improves life to a minimal extent. The explosive rise in the cost of healthcare has to be stopped one way or another. ... But it would probably make more sense to cut excessive consumption of medication than to cut back on therapies for rare diseases." (31/07/2012)
» more information (external link, Dutch)
More from the press review on the subject » Health Policy, » Ethics, » Society, » Netherlands